P-190 Potent pre-clinical activity of EP300/CBP bromodomain inhibitor CCS1477 in multiple myeloma

Autor: Frese, Kris, Nicosia, Luciano, Amaral, Fabio, Sinclair, Oliver, Pegg, Neil, West, Will, Knurowski, Tomasz, Clegg, Karen, Haynes, Debbie, Searle, Emma, Cavet, James, Somervaille, Tim
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 2:S140-S140
Databáze: ScienceDirect